Discovering potential interactions between rare diseases and COVID-19 by combining mechanistic models of viral infection with statistical modeling

被引:1
|
作者
Lopez-Sanchez, Macarena [1 ,2 ]
Loucera, Carlos [1 ,2 ]
Pena-Chilet, Maria [1 ,2 ,3 ]
Dopazo, Joaquin [1 ,2 ,3 ,4 ]
机构
[1] Hosp Virgen del Rocio, Fdn Progreso & Salud FPS, CDCA, Clin Bioinformat Area, Seville 41013, Spain
[2] Hosp Virgen del Rocio, Inst Biomed Seville IBIS, Computat Syst Med, Seville 41013, Spain
[3] Hosp Virgen del Rocio, Ctr Invest Biomed Red Enfermedades Raras CIBERER, FPS, Bioinformat Rare Dis BiER, Seville 41013, Spain
[4] Hosp Virgen del Rocio, FPS ELIXIR Es, Seville 42013, Spain
基金
欧盟地平线“2020”;
关键词
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; GENE; EXPRESSION; FRAMEWORK; PATHWAYS; TESTS;
D O I
10.1093/hmg/ddac007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Recent studies have demonstrated a relevant role of the host genetics in the coronavirus disease 2019 (COVID-19) prognosis. Most of the 7000 rare diseases described to date have a genetic component, typically highly penetrant. However, this vast spectrum of genetic variability remains yet unexplored with respect to possible interactions with COVID-19. Here, a mathematical mechanistic model of the COVID-19 molecular disease mechanism has been used to detect potential interactions between rare disease genes and the COVID-19 infection process and downstream consequences. Out of the 2518 disease genes analyzed, causative of 3854 rare diseases, a total of 254 genes have a direct effect on the COVID-19 molecular disease mechanism and 207 have an indirect effect revealed by a significant strong correlation. This remarkable potential of interaction occurs for >300 rare diseases. Mechanistic modeling of COVID-19 disease map has allowed a holistic systematic analysis of the potential interactions between the loss of function in known rare disease genes and the pathological consequences of COVID-19 infection. The results identify links between disease genes and COVID-19 hallmarks and demonstrate the usefulness of the proposed approach for future preventive measures in some rare diseases.
引用
收藏
页码:2078 / 2089
页数:12
相关论文
共 50 条
  • [1] Interactions between COVID-19 infection and diabetes
    Heshmati, Hassan M.
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2024, 14
  • [2] Selenium and selenoproteins in viral infection with potential relevance to COVID-19
    Zhang, Jinsong
    Saad, Ramy
    Taylor, Ethan Will
    Rayman, Margaret P.
    [J]. REDOX BIOLOGY, 2020, 37
  • [3] The line between COVID-19 pandemic and rare bone diseases
    Luca Sangiorgi
    Evelise Brizola
    [J]. Irish Journal of Medical Science (1971 -), 2021, 190 : 1243 - 1244
  • [4] The line between COVID-19 pandemic and rare bone diseases
    Sangiorgi, Luca
    Brizola, Evelise
    [J]. IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1243 - 1244
  • [5] Plant metabolites as potential therapeutics against COVID-19 and other viral diseases
    Kayesth, Sunil
    Chaudhary, Ashu
    Shazad, Mohd
    Saini, Priyanka
    Nisspatorn, Veeranoot
    Shah, Vijay Kumar
    Sharma, Chandni
    Sagar, Rohit
    Chaprana, Parveen
    Arora, Jyoti
    Zarubaev, Vladimir V.
    Gupta, Kamal Kumar
    [J]. INDIAN JOURNAL OF NATURAL PRODUCTS AND RESOURCES, 2024, 15 (02): : 201 - 223
  • [6] Modeling potential interactions between oral Gaucher disease treatment and investigational COVID-19 therapies
    Sahasrabudhe, Siddhee A.
    Al-Kofahi, Mahmoud
    Cloyd, James C.
    Weinreb, Neal
    Kartha, Reena V.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S93 - S94
  • [7] Collision between Two Pandemics: Obesity and COVID-19 Viral Infection
    Alrahimi, Jehan Saad
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (11) : 27 - 37
  • [8] Potential interactions between COVID-19 vaccines and antiepileptic drugs
    Kow, Chia Siang
    Hasan, Syed Shahzad
    [J]. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 86 : 80 - 81
  • [9] Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
    Gautam, Shashank Shekhar
    Gautam, C. S.
    Garg, Vivek Kumar
    Singh, Harmanjit
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (11) : 1183 - 1190
  • [10] Modeling in the Time of COVID-19: Statistical and Rule-based Mesoscale Models
    Nguyen, Ngan
    Strnad, Ondrej
    Klein, Tobias
    Luo, Deng
    Alharbi, Ruwayda
    Wonka, Peter
    Maritan, Martina
    Mindek, Peter
    Autin, Ludovic
    Goodsell, David S.
    Viola, Ivan
    [J]. IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS, 2021, 27 (02) : 722 - 732